NetworkNewsBreaks – Therma Bright Inc. (TSX.V: T
Post# of 62
(Total Views: 308)
Posted On: 03/08/2019 6:44:34 PM
NetworkNewsBreaks – Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Employs Trademarked Infrared Heat Technology to Protect the Body’s Largest Organ
Therma Bright (TSX.V: THRM) (OTC: THRBF) is focused on protecting the human body’s largest and fastest-growing organ, skin, which is a vital guard against damage to all other organs. An article discussing the company reads, “Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) is focusing its business mission on the development of innovative technologies that strengthen and sustain the body’s outer layer and help people to live healthier lives as a result. . . . The key to Therma Bright’s vision of enhancing health and wellness is to employ trademarked infrared heat technology against agents that attack the skin, such as insect stings, bites and viruses. The company’s TherOZap technology is a first-generation medical device approved by the U.S. Food and Drug Administration (“FDA”) for the relief of the symptoms of skin pain, itch and inflammation, but Therma Bright has been working on a corollary product that may establish a barrier against stinging and biting insects to combat the Zika virus and other mosquito-borne diseases such as dengue.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Therma Bright (TSX.V: THRM) (OTC: THRBF) is focused on protecting the human body’s largest and fastest-growing organ, skin, which is a vital guard against damage to all other organs. An article discussing the company reads, “Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) is focusing its business mission on the development of innovative technologies that strengthen and sustain the body’s outer layer and help people to live healthier lives as a result. . . . The key to Therma Bright’s vision of enhancing health and wellness is to employ trademarked infrared heat technology against agents that attack the skin, such as insect stings, bites and viruses. The company’s TherOZap technology is a first-generation medical device approved by the U.S. Food and Drug Administration (“FDA”) for the relief of the symptoms of skin pain, itch and inflammation, but Therma Bright has been working on a corollary product that may establish a barrier against stinging and biting insects to combat the Zika virus and other mosquito-borne diseases such as dengue.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Therma Bright, Inc. (TBRIF) Stock Research Links
Scroll down for more posts ▼